Gruss & Co. LLC acquired a new stake in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report) in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm acquired 4,000 shares of the exchange traded fund’s stock, valued at approximately $401,000. SPDR S&P Biotech ETF comprises approximately 1.0% of Gruss & Co. LLC’s holdings, making the stock its 16th biggest position.
A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Capital A Wealth Management LLC acquired a new position in SPDR S&P Biotech ETF during the 2nd quarter valued at about $26,000. Johnson Financial Group Inc. bought a new position in shares of SPDR S&P Biotech ETF in the second quarter valued at approximately $31,000. Twin Peaks Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF during the second quarter valued at approximately $32,000. Davis Capital Management bought a new stake in SPDR S&P Biotech ETF during the third quarter worth $35,000. Finally, Halbert Hargrove Global Advisors LLC bought a new stake in SPDR S&P Biotech ETF during the third quarter worth $40,000.
SPDR S&P Biotech ETF Trading Up 4.0%
Shares of NYSEARCA:XBI opened at $125.51 on Monday. The stock has a market cap of $8.39 billion, a PE ratio of 11.47 and a beta of 0.93. The stock’s fifty day simple moving average is $124.11 and its two-hundred day simple moving average is $108.74. SPDR S&P Biotech ETF has a 1-year low of $66.66 and a 1-year high of $132.09.
SPDR S&P Biotech ETF Company Profile
SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.
Recommended Stories
- Five stocks we like better than SPDR S&P Biotech ETF
- The day the gold market broke
- Your Bank Account Is No Longer Safe
- What a Former CIA Agent Knows About the Coming Collapse
- He just nailed another gold prediction …
- ~$1.5T SpaceX IPO: Pre-IPO Opportunity
Want to see what other hedge funds are holding XBI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for SPDR S&P Biotech ETF (NYSEARCA:XBI – Free Report).
Receive News & Ratings for SPDR S&P Biotech ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for SPDR S&P Biotech ETF and related companies with MarketBeat.com's FREE daily email newsletter.
